Screening for Severe Combined Immune Deficiency – Literature Review
An economic analysis of the cost-effectiveness of including testing for Severe Combined Immune Deficiency (SCID) in Newborn Metabolic Screening.
© Crown Copyright, Attribution 4.0 International (CC BY 4.0)
This literature review was intended to inform an economic analysis of the cost-effectiveness of including testing for Severe Combined Immune Deficiency (SCID) in the Newborn Metabolic Screening Programme. It was prepared for the National Screening Unit by Health Partners Consulting Group Ltd.